Video Experimental Relacionado
Updated: Jul 12, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.7K
Desarrollo de un vector de vacuna basado en paramixovirus J
Elizabeth R Wrobel1, Julia Paton-Smith1, Caroline Piotrowski1
1Department of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA, USA.
NPJ vaccines
|January 6, 2026
Resumen
Este estudio desarrolló un novedoso vector de vacuna de paramixovirus Jilin (JPV) completamente atenuado. Este nuevo vector JPV protege contra el desafío letal del virus Nipah después de una sola inmunización intranasal.
Área de la Ciencia:
- Virología
- Vacunología
- Biología Molecular
Sus antecedentes:
- El paramixovirus Jilin (JPV) es un virus de ARN de cadena negativa.
- Los vectores de JPV recombinante (rJPV) muestran promesa para el desarrollo de vacunas, pero pueden causar efectos adversos.
- Se necesita una mayor atenuación de los vectores de rJPV para plataformas de vacunas más seguras.
Objetivo del estudio:
- Desarrollar un vector de vacuna basado en JPV completamente atenuado.
- Evaluar la patogenicidad e inmunogenicidad de mutantes de rJPV modificados.
- Evaluar la eficacia protectora del nuevo vector contra el virus Nipah.
Principales métodos:
- Se generaron múltiples mutantes de rJPV mediante la deleción de genes específicos (SH, SP, X).
- Se introdujeron mutaciones en el gen L en rJPV-Δ3 para crear rJPV-Δ3-LW-L.
- Se probó la patogenicidad en ratones y la inmunogenicidad/eficacia en ratones y hámsteres utilizando la expresión de la proteína de fusión (F) del virus Nipah.
Principales resultados:
- El rJPV que carece de los genes SH, SP o SH/SP/X siguió siendo patógeno.
- El rJPV-Δ3 con mutaciones en el gen L (rJPV-Δ3-LW-L) se atenuó completamente en ratones.
- El rJPV-Δ3-LW-L que expresa F del NiV indujo anticuerpos anti-F del NiV y proporcionó protección completa contra el desafío letal del NiV en hámsteres.
Conclusiones:
- Se desarrolló con éxito un nuevo vector de vacuna intranasal JPV completamente atenuado (rJPV-Δ3-LW-L).
- Este vector demuestra potencial para la inmunización intranasal eficaz contra patógenos virales como el virus Nipah.
- Los hallazgos respaldan el avance de las plataformas de vacunas basadas en rJPV.
Videos de Conceptos Relacionados
01:51Vaccinations
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...